Evidence map›Paper›PMID 39744564›Full record

ArticleJournal of Cancer2025

Screening of Hub Genes and Therapeutic Drugs in Cervical Cancer Using Integrated Bioinformatics Analysis.

Ziruo Talihati, Kayisaier Abudurousuli, Sendaer Hailati, Mengyuan Han, Muhadaisi Nuer, Nawaz Khan, Nulibiya Maihemuti, Jimilihan Simayi, Weiyi Zhang, Wenting Zhou

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of Cancer, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Ziruo TalihatiDepartment of Pharmacology, School of Pharmacy, Xinjiang Medical University, Xinjiang, China.
Kayisaier AbudurousuliDepartment of Pharmacology, School of Pharmacy, Xinjiang Medical University, Xinjiang, China.
Sendaer HailatiDepartment of Pharmacology, School of Pharmacy, Xinjiang Medical University, Xinjiang, China.
Mengyuan HanDepartment of Pharmacology, School of Pharmacy, Xinjiang Medical University, Xinjiang, China.
Muhadaisi NuerDepartment of Pharmacology, School of Pharmacy, Xinjiang Medical University, Xinjiang, China.
Nawaz KhanDepartment of Pharmacology, School of Pharmacy, Xinjiang Medical University, Xinjiang, China.
Nulibiya MaihemutiDepartment of Pharmacology, School of Pharmacy, Xinjiang Medical University, Xinjiang, China.
Jimilihan SimayiDepartment of Pharmacology, School of Pharmacy, Xinjiang Medical University, Xinjiang, China.
Weiyi ZhangDepartment of Pharmacology, School of Pharmacy, Xinjiang Medical University, Xinjiang, China.
Wenting ZhouDepartment of Pharmacology, School of Pharmacy, Xinjiang Medical University, Xinjiang, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

BioinformaticsCervical cancerexperimental verificationPrognosisTraditional Chinese medicine

Identifiers

PMID39744564
PMCPMC11660142

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.